𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinicopathological staging of colorectal cancer: Has the time arrived?

✍ Scribed by N. C. Davis; E. B. Evans; J. R. Cohen; D. E. Theile; D. Job

Publisher
John Wiley and Sons
Year
1985
Tongue
English
Weight
237 KB
Volume
72
Category
Article
ISSN
0007-1323

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Value of serum acute-phase reactant prot
Value of serum acute-phase reactant proteins and carcinoembryonic antigen in the preoperative staging of colorectal cancer a multivariate analysis
✍ Apostolos P. Stamatiadis; Martha ST. Toumanidou; Gregory P. Vyssoulis; Andreas J πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 251 KB πŸ‘ 2 views

In 55 patients with benign or malignant neoplasias of the large bowel, serum carcinoembryonic antigen (CEA), C-reactive protein (CRP), alpha 1-antitrypsin (AAT), alpha 1-acid glycoprotein (AAG) levels, and the percentage of serum protein electrophoretic components were measured. Statistical analysis

Comparison between endoscopic and surgic
Comparison between endoscopic and surgical sampling for the measurement of potential doubling time in colorectal cancer
✍ Pierre Michel; Jacques Hemet; Marianne Paresy; Jean FranΓ§ois Menard; Annie Laque πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 52 KB πŸ‘ 2 views

In colorectal cancer, tumoral kinetic parameters could influence the therapeutic strategy. The aim of this study was to test the validity of a preoperative assessment of tumoral kinetics on biopsies obtained from endoscopic sampling. After infusion of 250 mg of bromodeoxyuridine (BrdUrd), tumor samp

Mutation of the transforming growth fact
Mutation of the transforming growth factor-Ξ² type II receptor gene in right-sided colorectal cancer: relationship to clinicopathological features and genetic alterations
✍ Iacopetta, Barry J.; Welch, John; Soong, Richie; House, Anthony K.; Zhou, Xiao-P πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 103 KB πŸ‘ 1 views

The presence of inactivating mutations in the transforming growth factor-beta (TGF-beta) type II receptor (RII) gene in the colon cancer suggests that it may behave like a tumour suppressor gene. RII is mutated in the majority of colon tumours exhibiting widespread microsatellite instability, a char